• Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Consensus Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 05 Feb 2025 02:31:09   America/Chicago


    Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat February 5, 2025 Share Link copied to clipboard. Shares of Arrowhead Pharmaceuticals, Inc.
    Read more...
Share on,